<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36238082</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1662-4548</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Frontiers in neuroscience</Title><ISOAbbreviation>Front Neurosci</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2, long COVID, prion disease and neurodegeneration.</ArticleTitle><Pagination><StartPage>1002770</StartPage><MedlinePgn>1002770</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1002770</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnins.2022.1002770</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Yuhai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Cell Biology and Anatomy, Louisiana State University Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>LSU Neuroscience Center, LSU Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaber</LastName><ForeName>Vivian R</ForeName><Initials>VR</Initials><AffiliationInfo><Affiliation>LSU Neuroscience Center, LSU Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lukiw</LastName><ForeName>Walter J</ForeName><Initials>WJ</Initials><AffiliationInfo><Affiliation>LSU Neuroscience Center, LSU Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Ophthalmology, LSU Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, LSU Health Sciences Center, New Orleans, LA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG018031</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG038834</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurosci</MedlineTA><NlmUniqueID>101478481</NlmUniqueID><ISSNLinking>1662-453X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease (AD)</Keyword><Keyword MajorTopicYN="N">Creutzfeldt-Jacob disease (CJD)</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">miRNA-146a</Keyword><Keyword MajorTopicYN="N">miRNA-155</Keyword><Keyword MajorTopicYN="N">prion disease (PrD)</Keyword><Keyword MajorTopicYN="N">&#x2018;S1&#x2019; spike protein</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>9</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>14</Day><Hour>2</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>15</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>9</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36238082</ArticleId><ArticleId IdType="pmc">PMC9551214</ArticleId><ArticleId IdType="doi">10.3389/fnins.2022.1002770</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Actis G. C., Ribaldone D. G., Pellicano R. (2021). COVID vaccine's hot problems: erratic serious blood clotting, ill-defined prion-like reactogenicity of the spike, unclear roles of other factors. Minerva Med. 112, 695&#x2013;697. 10.23736/S0026-4806.21.07769-7</Citation><ArticleIdList><ArticleId IdType="doi">10.23736/S0026-4806.21.07769-7</ArticleId><ArticleId IdType="pubmed">35168305</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S. J., Feigen C. M., Vazquez J. P., Kobets A. J., Altschul D. J. (2022). Neurological sequelae of COVID-19. J. Integr. Neurosci. 21, 77. 10.31083/j.jin2103077</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2103077</ArticleId><ArticleId IdType="pubmed">35633158</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayers J. I., Paras N. A., Prusiner S. B. (2020). Expanding spectrum of prion diseases. Emerg. Top Life Sci. 4, 155&#x2013;167. 10.1042/ETLS20200037</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/ETLS20200037</ArticleId><ArticleId IdType="pubmed">32803268</ArticleId></ArticleIdList></Reference><Reference><Citation>Baazaoui N., Iqbal K. (2022). COVID-19 and neurodegenerative diseases: prion-like spread and long-term consequences. J. Alzheimers Dis. 18. 10.3233/JAD-220105</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220105</ArticleId><ArticleId IdType="pubmed">35599487</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardini A., Gigli G. L., Janes F., Pellitteri G., Ciardi C., Fabris M., et al. . (2022). Creutzfeldt-Jakob disease after COVID-19: infection-induced prion protein misfolding? A case report. Prion. 16, 78&#x2013;83. 10.1080/19336896.2022.2095185</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19336896.2022.2095185</ArticleId><ArticleId IdType="pmc">PMC9255144</ArticleId><ArticleId IdType="pubmed">35786166</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson G. A., Prusiner S. B. (2021). How an infection of sheep revealed prion mechanisms in Alzheimer's disease and other neurodegenerative disorders. Int. J. Mol. Sci. 22, 4861. 10.3390/ijms22094861</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094861</ArticleId><ArticleId IdType="pmc">PMC8125442</ArticleId><ArticleId IdType="pubmed">34064393</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiricosta L., Gugliandolo A., Mazzon E. (2021). SARS-CoV-2 exacerbates beta-amyloid neurotoxicity, inflammation and oxidative stress in Alzheimer's disease patients. Int. J. Mol. Sci. 22, 13603. 10.3390/ijms222413603</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222413603</ArticleId><ArticleId IdType="pmc">PMC8705864</ArticleId><ArticleId IdType="pubmed">34948400</ArticleId></ArticleIdList></Reference><Reference><Citation>Choe K., Park H. Y., Ikram M., Lee H. J., Park T. J., Ullah R., et al. . (2022). Systematic review of the common pathophysiological mechanisms in covid-19 and neurodegeneration: The role of bioactive compounds and natural antioxidants. Cells. 11, 1298. 10.3390/cells11081298</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11081298</ArticleId><ArticleId IdType="pmc">PMC9031507</ArticleId><ArticleId IdType="pubmed">35455977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung S. J., Chang Y., Jeon J., Shin J. I., Song T. J., Kim J. (2022). Association of Alzheimer's disease with COVID-19 susceptibility and severe complications: a nationwide cohort study. J. Alzheimers Dis. 87, 701&#x2013;710. 10.3233/JAD-220031</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-220031</ArticleId><ArticleId IdType="pubmed">35275548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccio M., Lo Sasso B., Scazzone C., Gambino C. M., Ciaccio A. M., Bivona G., et al. . (2021). COVID-19 and Alzheimer's disease. Brain Sci. 11, 305. 10.3390/brainsci11030305</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030305</ArticleId><ArticleId IdType="pmc">PMC7997244</ArticleId><ArticleId IdType="pubmed">33673697</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciolac D., Racila R., Duarte C., Vasilieva M., Manea D., Gorincioi N., et al. . (2021). Clinical and radiological deterioration in a case of Creutzfeldt-Jakob Disease following SARS-CoV-2 Infection: hints to accelerated age-dependent neurodegeneration. Biomedicines. 9, 1730. 10.3390/biomedicines9111730</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9111730</ArticleId><ArticleId IdType="pmc">PMC8615966</ArticleId><ArticleId IdType="pubmed">34829958</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen T. M., Sandoval D. R., Spliid C. B., Pihl J., Perrett H. R., Painter C. D., et al. . (2020). SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 183, 1043&#x2013;1057.e15. 10.1016/j.cell.2020.09.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.033</ArticleId><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai L., Gao G. F. (2021). Viral targets for vaccines against COVID-19. Nat. Rev. Immunol. 21, 73&#x2013;82. 10.1038/s41577-020-00480-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00480-0</ArticleId><ArticleId IdType="pmc">PMC7747004</ArticleId><ArticleId IdType="pubmed">33340022</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q., Shults N. V., Gychka S. G., Harris B. T., Suzuki Y. J. (2021). Protein expression of angiotensin-converting enzyme 2 (ACE2) is upregulated in brains with Alzheimer's disease. Int. J. Mol. Sci. 22, 1687. 10.3390/ijms22041687</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041687</ArticleId><ArticleId IdType="pmc">PMC7914443</ArticleId><ArticleId IdType="pubmed">33567524</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan L., Zheng Q., Zhang H., Niu Y., Lou Y., Wang H. (2020). The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. Front. Immunol. 11, 576622. 10.3389/fimmu.2020.576622</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.576622</ArticleId><ArticleId IdType="pmc">PMC7575906</ArticleId><ArticleId IdType="pubmed">33117378</ArticleId></ArticleIdList></Reference><Reference><Citation>Eymieux S., Uzbekov R., Rouill&#xe9; Y., Blanchard E., Hourioux C., Dubuisson J., et al. . (2021). Secretory vesicles are the principal means of SARS-CoV-2 egress. Cells. 10, 2047. 10.3390/cells10082047</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10082047</ArticleId><ArticleId IdType="pmc">PMC8393858</ArticleId><ArticleId IdType="pubmed">34440816</ArticleId></ArticleIdList></Reference><Reference><Citation>Farheen S., Agrawal S., Zubair S., Agrawal A., Jamal F., Altaf I., et al. . (2021). Patho-physiology of aging and immune-senescence: possible correlates with comorbidity and mortality in middle-aged and old COVID-19 patients. Front. Aging. 2, 748591. 10.3389/fragi.2021.748591</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fragi.2021.748591</ArticleId><ArticleId IdType="pmc">PMC9261314</ArticleId><ArticleId IdType="pubmed">35822018</ArticleId></ArticleIdList></Reference><Reference><Citation>Flud V. V., Shcherbuk Y. A., Shcherbuk A. Y., Leonov V. I., Al-Sahli O. A. (2022). Neurological complications and consequences of new coronavirus COVID-19 infection in elderly and old patients. Adv. Gerontol. 35, 231&#x2013;242. 10.34922/AE.2022.35.2.007</Citation><ArticleIdList><ArticleId IdType="doi">10.34922/AE.2022.35.2.007</ArticleId><ArticleId IdType="pubmed">35727930</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu Y. W., Xu H. S., Liu S. J. (2022). COVID-19 and neurodegenerative diseases. Eur. Rev. Med. Pharmacol Sci. 26, 4535&#x2013;4544. 10.26355/eurrev_202206_29093</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202206_29093</ArticleId><ArticleId IdType="pubmed">35776055</ArticleId></ArticleIdList></Reference><Reference><Citation>Geschwind M. D. (2015). Prion diseases. Continuum. 21, 1612&#x2013;1638. 10.1212/CON.0000000000000251</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000251</ArticleId><ArticleId IdType="pmc">PMC4879966</ArticleId><ArticleId IdType="pubmed">26633779</ArticleId></ArticleIdList></Reference><Reference><Citation>Guasp M., Mu&#xf1;oz-S&#xe1;nchez G., Mart&#xed;nez-Hern&#xe1;ndez E., Santana D., Carbayo &#xc1;., Naranjo L. (2022). CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome. Front. Immunol. 13, 866153. 10.3389/fimmu.2022.866153</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.866153</ArticleId><ArticleId IdType="pmc">PMC9035899</ArticleId><ArticleId IdType="pubmed">35479062</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill J. M., Clement C., Arceneaux L., Lukiw W. J. (2021). Angiotensin converting enzyme 2 (ACE2) expression in the aged brain and visual system. J. Aging. Sci. 9, 7.001. 10.21203/rs.3.rs-296818/v1</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-296818/v1</ArticleId><ArticleId IdType="pmc">PMC8580311</ArticleId><ArticleId IdType="pubmed">34765681</ArticleId></ArticleIdList></Reference><Reference><Citation>Hixon A. M., Thaker A. A., Pelak V. S. (2021). Persistent visual dysfunction following posterior reversible encephalopathy syndrome due to COVID-19. Eur. J. Neurol. 28, 3289&#x2013;3302. 10.1111/ene.14965</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14965</ArticleId><ArticleId IdType="pmc">PMC8444757</ArticleId><ArticleId IdType="pubmed">34115917</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes C., Cunningham C., Perry V. H. (2010). Systemic inflammation and disease progression in Alzheimer disease. Neurology. 74, 1157&#x2013;1158. 10.1212/WNL.0b013e3181d5df7f</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181d5df7f</ArticleId><ArticleId IdType="pmc">PMC2848584</ArticleId><ArticleId IdType="pubmed">19738171</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu J. T., Tien C. F., Yu G. Y., Shen S., Lee Y. H., Hsu P. C., et al. . (2021). The effects of A&#x3b2;1 &#x2212; 42 binding to the SARS-CoV-2 spike protein S1 subunit and angiotensin-converting enzyme 2. Int. J. Mol. Sci. 22, 8226. 10.3390/ijms22158226</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22158226</ArticleId><ArticleId IdType="pmc">PMC8347908</ArticleId><ArticleId IdType="pubmed">34360989</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 395, 497&#x2013;506. 10.1016/S0140-6736(20)30183-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. (2021). SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem. Biophys. Res. Commun. 554, 94&#x2013;98. 10.1016/j.bbrc.2021.03.100</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ke Z., Oton J., Qu K., Cortese M., Zila V., McKeane L., et al. . (2020). Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature. 588, 498&#x2013;502. 10.1038/s41586-020-2665-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2665-2</ArticleId><ArticleId IdType="pmc">PMC7116492</ArticleId><ArticleId IdType="pubmed">32805734</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirtipal N., Kumar S., Dubey S. K., Dwivedi V. D., Gireesh Babu K., Mal&#xfd; P., Bharadwaj S. (2022). Understanding on the possible routes for SARS CoV-2 invasion via ACE2 in the host linked with multiple organ damage. Infect. Genet. E 99, 105254. 10.1016/j.meegid.2022.105254</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105254</ArticleId><ArticleId IdType="pmc">PMC8863418</ArticleId><ArticleId IdType="pubmed">35217145</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiyoshi C. M., Zhou M. (2019). Astrocyte syncytium: a functional reticular system in the brain. Neural. Regen. Res. 14, 595&#x2013;596. 10.4103/1673-5374.247462</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.247462</ArticleId><ArticleId IdType="pmc">PMC6352602</ArticleId><ArticleId IdType="pubmed">30632498</ArticleId></ArticleIdList></Reference><Reference><Citation>Krey L., Huber M. K., H&#xf6;glinger G. U., Wegner F. (2021). Can SARS-CoV2 infection lead to neurodegeneration and Parkinson's disease? Brain. Sci. 11, 1654. 10.3390/brainsci11121654</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11121654</ArticleId><ArticleId IdType="pmc">PMC8699589</ArticleId><ArticleId IdType="pubmed">34942956</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuvandik A., Ozcan E., Serin S., Sungurtekin H. (2021). Creutzfeldt-Jakob disease after the COVID-19 vaccination. Turk J. Intensive Care. 10.4274/tybd.galenos.2021.91885</Citation><ArticleIdList><ArticleId IdType="doi">10.4274/tybd.galenos.2021.91885</ArticleId></ArticleIdList></Reference><Reference><Citation>Letarov A. V., Babenko V. V., Kulikov E. E. (2021). Free SARS-CoV-2 spike protein S1 particles may play a role in the pathogenesis of COVID-19 infection. Biochemistry. 86, 257&#x2013;261. 10.1134/S0006297921030032</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297921030032</ArticleId><ArticleId IdType="pmc">PMC7772528</ArticleId><ArticleId IdType="pubmed">33838638</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K. H., Yang S., Kim S. H., Joo J. Y. (2020). Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer's disease. J. Infect. 81, e33&#x2013;e34. 10.1016/j.jinf.2020.06.072</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.072</ArticleId><ArticleId IdType="pmc">PMC7834154</ArticleId><ArticleId IdType="pubmed">32619698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lingor P., Demleitner A. F., Wolff A. W., Feneberg E. (2022). SARS-CoV-2 and neurodegenerative diseases: what we know and what we don't. J. Neural. Transm. 129:1155&#x2013;1167. 10.1007/s00702-022-02500-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02500-w</ArticleId><ArticleId IdType="pmc">PMC9013492</ArticleId><ArticleId IdType="pubmed">35434769</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y., Sun Z. (2022). SARS-CoV-2 molecular diagnostics in China. Clin. Lab. Med. 42, 193&#x2013;201. 10.1016/j.cll.2022.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cll.2022.03.003</ArticleId><ArticleId IdType="pmc">PMC8894802</ArticleId><ArticleId IdType="pubmed">35636821</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W. J. (2022). David Hunter Hubel, the 'Circe effect', and SARS-CoV-2 infection of the human visual system. Front. Biosci. 27, 7. 10.31083/j.fbl2701007</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.fbl2701007</ArticleId><ArticleId IdType="pubmed">35090312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W. J., Jaber V. R., Pogue A. I., Zhao Y. (2022). SARS-CoV-2 invasion and pathological links to prion disease. Biomolecules. (In press). 10.3390/biom12091253</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12091253</ArticleId><ArticleId IdType="pmc">PMC9496025</ArticleId><ArticleId IdType="pubmed">36139092</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q. (2020). Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 77:683&#x2013;690. 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercatelli D., Giorgi F. M. (2020). Geographic and genomic distribution of SARS-CoV-2 mutations. Front. Microbiol. 11, 1800. 10.3389/fmicb.2020.01800</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.01800</ArticleId><ArticleId IdType="pmc">PMC7387429</ArticleId><ArticleId IdType="pubmed">32793182</ArticleId></ArticleIdList></Reference><Reference><Citation>Molina-Molina M., Hern&#xe1;ndez-Argudo M. (2022). Respiratory consequences after COVID-19: outcome and treatment. Rev. Esp. Quimioter. 35, 67&#x2013;72. 10.37201/req/s01.16.2022</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/s01.16.2022</ArticleId><ArticleId IdType="pmc">PMC9106190</ArticleId><ArticleId IdType="pubmed">35488831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavizadeh L., Ghasemi S. (2021). Genotype and phenotype of COVID19: their roles in pathogenesis. J. Microbiol. Immunol. Infect. 54, 159&#x2013;163. 10.1016/j.jmii.2020.03.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.022</ArticleId><ArticleId IdType="pmc">PMC7138183</ArticleId><ArticleId IdType="pubmed">32265180</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;oz-Jurado A., Escribano B. M., Ag&#xfc;era E., Caballero-Villarraso J., Galv&#xe1;n A., T&#xfa;nez I. (2022). SARS-CoV-2 infection in multiple sclerosis patients: interaction with treatments, adjuvant therapies, and vaccines against COVID-19. J. Neurol. 269, 4581&#x2013;4603. 10.1007/s00415-022-11237-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11237-1</ArticleId><ArticleId IdType="pmc">PMC9253265</ArticleId><ArticleId IdType="pubmed">35788744</ArticleId></ArticleIdList></Reference><Reference><Citation>Oldfield P. R., Hibberd J., Bridle B. W. (2021). How does severe acute respiratory syndrome-coronavirus-2 affect the brain and its implications for the vaccines currently in use. Vaccines. 10, 1. 10.3390/vaccines10010001</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10010001</ArticleId><ArticleId IdType="pmc">PMC8780773</ArticleId><ArticleId IdType="pubmed">35062662</ArticleId></ArticleIdList></Reference><Reference><Citation>Olivo S., Furlanis G., Buoite Stella A., Fabris M., Milanic R., Zanusso G., et al. . (2022). Rapidly evolving Creutzfeldt-Jakob disease in COVID-19: from early status epilepticus to fatal outcome. Acta Neurol. Belg. 19:1&#x2013;4. 10.1007/s13760-022-02023-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-022-02023-x</ArticleId><ArticleId IdType="pmc">PMC9294798</ArticleId><ArticleId IdType="pubmed">35852764</ArticleId></ArticleIdList></Reference><Reference><Citation>Paiardi G., Richter S., Oreste P., Urbinati C., Rusnati M., Wade R. C. (2022). The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms. J. Biol. Chem. 298, 101507. 10.1016/j.jbc.2021.101507</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2021.101507</ArticleId><ArticleId IdType="pmc">PMC8683219</ArticleId><ArticleId IdType="pubmed">34929169</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios-R&#xe1;palo S. N., Jes&#xfa;s-Gonz&#xe1;lez L. A. D., Cordero-Rivera C. D., FarfanMorales C. N., Osuna-Ramos J. F., et al. . (2021). Cholesterol-rich lipid rafts as platforms for SARS-CoV-2 entry. Front. Immunol. 12, 796855. 10.3389/fimmu.2021.796855</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.796855</ArticleId><ArticleId IdType="pmc">PMC8719300</ArticleId><ArticleId IdType="pubmed">34975904</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekut T., Hur&#x142;a M., Banaszek N., Szejn P., Dorszewska J., Kozubski W. (2022). Infectious agents and Alzheimer's disease. J. Integr. Neurosci. 21, 73. 10.31083/j.jin2102073</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2102073</ArticleId><ArticleId IdType="pubmed">35364661</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinacchio C., Scordio M., Santinelli L., Frasca F., Sorrentino L., Bitossi C., et al. . (2022). Analysis of serum microRNAs and rs2910164 GC single-nucleotide polymorphism of miRNA-146a in COVID-19 patients. J. Immunoassay Immunochem. 43, 347&#x2013;364. 10.1080/15321819.2022.2035394</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819.2022.2035394</ArticleId><ArticleId IdType="pubmed">35227165</ArticleId></ArticleIdList></Reference><Reference><Citation>Piras M., Cau F., Manchia M., Paribello P., Saba L., Suri J. S. G., et al. . (2022). Strong ACE-2 expression in the choroidal vessels: do high choroid plexuses serve as a gateway for SARS-CoV-2 infection on the human brain? Eur. Rev. Med. Pharmacol. Sci. 26, 3025&#x2013;3029. 10.26355/eurrev_202204_28633</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_202204_28633</ArticleId><ArticleId IdType="pubmed">35503602</ArticleId></ArticleIdList></Reference><Reference><Citation>Pogue A. I., Lukiw W. J. (2021). microRNA-146a-5p, neurotropic viral infection and prion disease (PrD). Int. J. Mol. Sci. 22, 9198. 10.3390/ijms22179198</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22179198</ArticleId><ArticleId IdType="pmc">PMC8431499</ArticleId><ArticleId IdType="pubmed">34502105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchien K., Chan D., Watermeyer T. (2020). The cognitive consequences of the COVID-19 epidemic: Collateral damage? Brain Commun. 2, fcaa069. 10.1093/braincomms/fcaa069</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa069</ArticleId><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Rivas J., Croce G., Muscat M., Weigt M. (2022). Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes. Proc. Natl. Acad. Sci. USA. 119, e2113118119. 10.1073/pnas.2113118119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2113118119</ArticleId><ArticleId IdType="pmc">PMC8795541</ArticleId><ArticleId IdType="pubmed">35022216</ArticleId></ArticleIdList></Reference><Reference><Citation>Roganovi&#x107; J. R. (2021). microRNA-146a and&#x2212;155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptor genes. J. Periodontol. 92, 35&#x2013;43. 10.1002/JPER.20-0623</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/JPER.20-0623</ArticleId><ArticleId IdType="pubmed">33336412</ArticleId></ArticleIdList></Reference><Reference><Citation>Roy D., Ghosh R., Dubey S., Dubey M. J., Benito-Le&#xf3;n J., Kanti Ray B. (2021). Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can. J. Neurol. Sci. 48, 9&#x2013;24. 10.1017/cjn.2020.173</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2020.173</ArticleId><ArticleId IdType="pmc">PMC7533477</ArticleId><ArticleId IdType="pubmed">32753076</ArticleId></ArticleIdList></Reference><Reference><Citation>Sah R., Rodriguez-Morales A. J., Jha R., Chu D. K. W., Gu H., Peiris M. (2020). Complete genome sequence of a 2019 novel coronavirus (SARSCoV-2) strain isolated in Nepal. Microbiol. Resour. Announc. 9, e169&#x2013;e220. 10.1128/MRA.00169-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MRA.00169-20</ArticleId><ArticleId IdType="pmc">PMC7067954</ArticleId><ArticleId IdType="pubmed">32165386</ArticleId></ArticleIdList></Reference><Reference><Citation>Saheera S., Potnuri A. G., Krishnamurthy P. (2020). Nano-vesicle mis-communication in senescence-related pathologies. Cells. 9, 1974. 10.3390/cells9091974</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9091974</ArticleId><ArticleId IdType="pmc">PMC7564330</ArticleId><ArticleId IdType="pubmed">32859053</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahzad S., Willcox M. (2022). The possible role of prion-like viral protein domains on the emergence of novel viruses as SARS-CoV-2. J. Mol. Evol. 90, 227&#x2013;230. 10.1007/s00239-022-10054-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00239-022-10054-4</ArticleId><ArticleId IdType="pmc">PMC8972983</ArticleId><ArticleId IdType="pubmed">35362781</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen W. B., Logue J., Yang P., Baracco L., Elahi M., Reece E. A., et al. . (2022). SARS-CoV-2 invades cognitive centers of the brain and induces Alzheimer's-like neuropathology. bioRxiv. 10.1101/2022.01.31.478476</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2022.01.31.478476</ArticleId><ArticleId IdType="pmc">PMC8820661</ArticleId><ArticleId IdType="pubmed">35132414</ArticleId></ArticleIdList></Reference><Reference><Citation>Sirin S., Nigdelioglu Dolanbay S., Aslim B. (2022). The relationship of early- and late-onset Alzheimer's disease genes with COVID-19. J. Neural. Transm. 129:847&#x2013;859. 10.1007/s00702-022-02499-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-022-02499-0</ArticleId><ArticleId IdType="pmc">PMC9012910</ArticleId><ArticleId IdType="pubmed">35429259</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A. V., Skriabine S., et al. . (2021). Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 218, e20202135. 10.1101/2020.06.25.169946</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.06.25.169946</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabo M. P., Iba M., Nath A., Masliah E., Kim C. (2022). Does SARS-CoV-2 affect neurodegenerative disorders? TLR2, a potential receptor for SARS-CoV-2. Exp. Mol. Med. 54:447&#x2013;454. 10.1038/s12276-022-00755-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-022-00755-7</ArticleId><ArticleId IdType="pmc">PMC8990637</ArticleId><ArticleId IdType="pubmed">35396576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoly O., Safavi F., Tavassoly I. (2020a). Heparin-binding peptides as novel therapies to stop SARS-CoV-2 cellular entry and infection. Mol. Pharmacol. 98, 612&#x2013;619. 10.1124/molpharm.120.000098</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/molpharm.120.000098</ArticleId><ArticleId IdType="pmc">PMC7610036</ArticleId><ArticleId IdType="pubmed">32913137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavassoly O., Safavi F., Tavassoly I. (2020b). Seeding brain protein aggregation by SARS-CoV-2 as a possible long-term complication of COVID-19 infection. ACS Chem. Neurosci. 11, 3704&#x2013;3706. 10.1021/acschemneuro.0c00676</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00676</ArticleId><ArticleId IdType="pubmed">33147014</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayyebi G., Malakouti S. K., Shariati B., Kamalzadeh L. (2022). COVID-19-associated encephalitis or Creutzfeldt-Jakob disease: a case report. Neurodegener. Dis. Manag. 12, 29&#x2013;34. 10.2217/nmt-2021-0025</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt-2021-0025</ArticleId><ArticleId IdType="pmc">PMC8765092</ArticleId><ArticleId IdType="pubmed">34854312</ArticleId></ArticleIdList></Reference><Reference><Citation>Tetz G., Tetz V. (2022). Prion-like domains in spike protein of SARS-CoV-2 differ across its variants and enable changes in affinity to ACE2. Microorganisms. 10, 280. 10.3390/microorganisms10020280</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms10020280</ArticleId><ArticleId IdType="pmc">PMC8878784</ArticleId><ArticleId IdType="pubmed">35208734</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisdale A. K., Dinkin M., Chwalisz BK. (2021). Afferent and efferent neuro-ophthalmic complications of Coronavirus disease 19. J. Neuroophthalmol. 41, 154&#x2013;165. 10.1097/WNO.0000000000001276</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNO.0000000000001276</ArticleId><ArticleId IdType="pubmed">33935220</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigasova D., Nemergut M., Liskova B., Damborsky J. (2021). Multi-pathogen infections and Alzheimer's disease. Microb. Cell. Fact. 20, 25. 10.1186/s12934-021-01520-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12934-021-01520-7</ArticleId><ArticleId IdType="pmc">PMC7844946</ArticleId><ArticleId IdType="pubmed">33509204</ArticleId></ArticleIdList></Reference><Reference><Citation>Visco V., Vitale C., Rispoli A., Izzo C., Virtuoso N., Ferruzzi G. J. (2022). Post-COVID-19 syndrome: involvement and interactions between respiratory, cardiovascular and nervous systems. J. Clin. Med. 11, 524. 10.3390/jcm11030524</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030524</ArticleId><ArticleId IdType="pmc">PMC8836767</ArticleId><ArticleId IdType="pubmed">35159974</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu F., Zhao S., Yu B., Chen Y. M., Wang W., Song Z. G. (2020). A new coronavirus associated with human respiratory disease in China. Nature. 579, 265&#x2013;269. 10.1038/s41586-020-2008-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2008-3</ArticleId><ArticleId IdType="pmc">PMC7094943</ArticleId><ArticleId IdType="pubmed">32015508</ArticleId></ArticleIdList></Reference><Reference><Citation>Young M. J., O'Hare M., Matiello M., Schmahmann J. D. (2020). Creutzfeldt-Jakob disease in a man with COVID-19: SARS-CoV-2-accelerated neurodegeneration? Brain Behav. Immun. 89, 601&#x2013;603. 10.1016/j.bbi.2020.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.007</ArticleId><ArticleId IdType="pmc">PMC7362815</ArticleId><ArticleId IdType="pubmed">32681865</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H., Schott J. M. (2022). Blood biomarkers for Alzheimer's disease. Acta Neurol. Scand. 146:51&#x2013;55. 10.1111/ane.13628</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13628</ArticleId><ArticleId IdType="pubmed">35470421</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Jaber V., Alexandrov P. N., Vergallo A., Lista S., Hampel H., et al. . (2020). microRNA-based biomarkers in Alzheimer's disease (AD). Front. Neurosci. 14, 585432. 10.3389/fnins.2020.585432</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.585432</ArticleId><ArticleId IdType="pmc">PMC7664832</ArticleId><ArticleId IdType="pubmed">33192270</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Li W., Lukiw W. J. (2021). Ubiquity of the SARS-CoV-2 receptor ACE2 and upregulation in limbic regions of Alzheimer's disease brain. Folia Neuropathol. 59, 232&#x2013;238. 10.5114/fn.2021.109495</Citation><ArticleIdList><ArticleId IdType="doi">10.5114/fn.2021.109495</ArticleId><ArticleId IdType="pubmed">34628788</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y., Lukiw W. J. (2022). SARS-CoV-2 neuroinvasion, inflammatory neurodegeneration and Alzheimer's disease. Front. Cell Neurosci. 16, 937961. 10.3389/fncel.2022.937961</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2022.937961</ArticleId><ArticleId IdType="pmc">PMC9247146</ArticleId><ArticleId IdType="pubmed">35783095</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Xu J., Hou Y., Leverenz J. B., Kallianpur A., Mehra R., et al. . (2021). Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment. Alzheimers Res. Ther. 13, 110. 10.1186/s13195-021-00850-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00850-3</ArticleId><ArticleId IdType="pmc">PMC8189279</ArticleId><ArticleId IdType="pubmed">34108016</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>